Company Analysis
Sign in

Quanterix Corporation (QTRX)

Nasdaq: QTRX · Laboratory Analytical Instruments · Billerica, MA · filing with the SEC since 2010
Full chart Alerts Compare
Grade3.8
◀ Past 3.6● Present 3.8▶ Future 4.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

48 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Quanterix Corporation’s names, not what it holds today.

Patents granted
48
48 utility, 1976 to Dec 31, 2025
Granted in 2025
5
Against 6 in 2024 and 2 in 2023
Applications published
82
7 of them in 2025
Names they are printed under
6
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Measurement8
Analysis of biological materials6
Biotechnology3
Medical technology3
Chemical engineering1
Optics1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
QUANTERIX CORPORATION its own name
US, as the owner printed on each patent
27 granted
50 published
Akoya Biosciences, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
19 published
Aushon Biosystems, Inc. a subsidiary
US, as the owner printed on each patent
10 granted
9 published
Akoya Biosciences, Inc. a subsidiary
US, as the owner printed on each patent
9 granted
0 published
Emission Inc. a subsidiary
US, as the owner printed on each patent
2 granted
2 published
Aushon Biosystems, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 11, 202512,467,847Compact flow cytometer and method of useMeasurementEmission Inc.
Apr 29, 202512,287,343Quantification of neurofilament light chain in physiological samplesMedical technologyQUANTERIX CORPORATION
Apr 22, 202512,281,355Multiplexed imaging with enzyme mediated amplificationBiotechnologyAkoya Biosciences, Inc.
Feb 25, 202512,235,267Ultra-sensitive detection of molecules or particles using beads or other capture objectsAnalysis of biological materialsQUANTERIX CORPORATION
Feb 25, 202512,235,215Processing and imaging tissue samplesMeasurementAkoya Biosciences, Inc.
Oct 29, 202412,130,294Quantification of biomarkers present in physiological samplesMedical technologyQUANTERIX CORPORATION
Oct 8, 202412,111,324Quantification of biomarkers present in dried physiological samplesMedical technologyQUANTERIX CORPORATION
Jun 25, 202412,019,072Methods and systems for extending dynamic range in assays for the detection of molecules or particlesAnalysis of biological materialsQUANTERIX CORPORATION
May 28, 202411,994,452Multiplexed tissue imagingMeasurementAkoya Biosciences, Inc.
May 7, 202411,977,087Systems, devices, and methods for ultra-sensitive detection of molecules or particlesMeasurementQUANTERIX CORPORATION
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0389659PROCESSING AND IMAGING TISSUE SAMPLESMeasurementAkoya Biosciences, Inc.
Nov 6, 20252025/0341530QUANTIFICATION OF NEUROFILAMENT LIGHT CHAIN IN PHYSIOLOGICAL SAMPLESMedical technologyQUANTERIX CORPORATION
Jun 26, 20252025/0208150METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT’S RECOVERY FROM A BRAIN INJURYAnalysis of biological materialsQUANTERIX CORPORATION
Jun 26, 20252025/0207180SPATIALLY RESOLVED CYCLIC MULTIPLEXED DETECTION OF NUCLEIC ACIDS AND PROTEINS IN TISSUEBiotechnologyAkoya Biosciences, Inc.
Jun 5, 20252025/0180553ULTRA-SENSITIVE DETECTION OF MOLECULES OR PARTICLES USING BEADS OR OTHER CAPTURE OBJECTSAnalysis of biological materialsQUANTERIX CORPORATION
Apr 3, 20252025/0110027MULTIPLEXED TISSUE IMAGINGMeasurementAkoya Biosciences, Inc.
Feb 13, 20252025/0052979SURFACE SENSING IN AUTOMATED SAMPLE ANALYSISOpticsAkoya Biosciences, Inc.
Nov 14, 20242024/0377397METHODS AND SYSTEMS FOR EXTENDING DYNAMIC RANGE IN ASSAYS FOR THE DETECTION OF MOLECULES OR PARTICLESAnalysis of biological materialsQUANTERIX CORPORATION
Sep 5, 20242024/0295552ULTRA-SENSITIVE DETECTION OF MOLECULES OR PARTICLES USING BEADS OR OTHER CAPTURE OBJECTSAnalysis of biological materialsQUANTERIX CORPORATION · patent 12,235,267 granted from it
Jun 20, 20242024/0201175METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT’S RECOVERY FROM A BRAIN INJURY RESULTING FROM A HYPOXIC EVENTAnalysis of biological materialsQUANTERIX CORPORATION
What it applied for, 2024 to 2025: Analysis of biological materials 5 · Biotechnology 2 · Measurement 2 · Optics 1 · Medical technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton QTRX · research, not advice